Search research articles
Contact Us
Filters
Showing results (71-80 of 250) with videos related to
Page
of 25
Sort By:
Medicinal Research Reviews
|
November 11, 2020
Optimizing clinical research procedures in public health emergencies
Ainhoa Madariaga, Lawrence Kasherman, Katherine Karakasis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 8, 2010
Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer
Danny Rischin, Kailash Narayan, Amit M Oza, et al.
Gynecologic Oncology
|
August 14, 2013
Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer
Rachel A Goodwin, Rahima Jamal, Dongsheng Tu, et al.
Cancer
|
January 24, 2007
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses
Laurie Elit, Thomas K Oliver, Allan Covens, et al.
Nature Reviews. Clinical Oncology
|
October 2, 2023
Heterogeneity and treatment landscape of ovarian carcinoma
Ana C Veneziani, Eduardo Gonzalez-Ochoa, Husam Alqaisi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2005
Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors
Eric H Rubin, John Rothermel, Fisseha Tesfaye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2020
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, et al.
BMC Cancer
|
October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?
Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)
Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium
Stephen A Welch, Hal W Hirte, Laurie Elit, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 250) with videos related to
Sort By:
Page
of 25
Medicinal Research Reviews
|
November 11, 2020
Optimizing clinical research procedures in public health emergencies
Ainhoa Madariaga, Lawrence Kasherman, Katherine Karakasis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 8, 2010
Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer
Danny Rischin, Kailash Narayan, Amit M Oza, et al.
Gynecologic Oncology
|
August 14, 2013
Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer
Rachel A Goodwin, Rahima Jamal, Dongsheng Tu, et al.
Cancer
|
January 24, 2007
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses
Laurie Elit, Thomas K Oliver, Allan Covens, et al.
Nature Reviews. Clinical Oncology
|
October 2, 2023
Heterogeneity and treatment landscape of ovarian carcinoma
Ana C Veneziani, Eduardo Gonzalez-Ochoa, Husam Alqaisi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2005
Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors
Eric H Rubin, John Rothermel, Fisseha Tesfaye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2020
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, et al.
BMC Cancer
|
October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?
Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)
Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium
Stephen A Welch, Hal W Hirte, Laurie Elit, et al.
Page
of 25